A study suggests twice-yearly Yeztugo offers HIV prevention without adversely affecting gender-affirming care.

“Gedatolisib plus Faslodex, with or without Ibrance, represents a potential new standard of care for patients with hormone ...

Every year, there’s a new lineup of such curious clinical conditions. There are always some unfortunate souls to mark medical ...

Prevalence of Electrolyte Disorders in Oncology: Descriptive Cross-Sectional Study in the Cancer Department of the National ...

Al-Gahtani, S. (2026) Review of Literature Investigating the Correlation between Prevalence of Risk Factors Associated with ...

The Centers for Disease Control (CDC) said it is planning to expand eligibility for publicly funded HIV treatment for foreign nationals next year, but has not revealed details of the plan. CDC ...

The CLL17 trial showed noninferiority of fixed-duration regimens compared to continuous BTK inhibitor therapy, highlighting ...

On December 29, 2025, Tonix Pharma ceuticals announced updated plans for its TNX-4800 Lyme disease prophylaxis program, including a scheduled 2026 meeting with the U.S. Food and D ...

FREE Study to evaluate the efficacy and safety of ARAKODA® (tafenoquine) for treatment of chronic babesiosisData support ...

Exploring clinical development plan options including a controlled human infection model (CHIM) and a Phase 2/3 adaptive ...

Counterfeit rabies vaccine Abhayrab® circulating in India may leave people unprotected. Those vaccinated since November 2023 ...

There is no reliable scientific documentation of rabies being transmitted through the ingestion of milk or milk products ...